Repertoire Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sotera Health
SHC
|
+$2.36M |
| 2 |
SGI
Somnigroup International
SGI
|
+$2.22M |
| 3 |
ETWO
E2open Parent Holdings
ETWO
|
+$1.98M |
| 4 |
SNBR
Sleep Number
SNBR
|
+$1.65M |
| 5 |
Match Group
MTCH
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSG
Octave Specialty Group
OSG
|
+$9.69M |
| 2 |
Perimeter Solutions
PRM
|
+$9.15M |
| 3 |
Cable One
CABO
|
+$8.65M |
| 4 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$2.89M |
| 5 |
Warner Music
WMG
|
+$2.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 62.4% |
| 2 | Materials | 11.5% |
| 3 | Communication Services | 6.74% |
| 4 | Consumer Discretionary | 5.63% |
| 5 | Technology | 4.31% |
Similar funds
Repertoire Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Repertoire Partners held 22 positions worth $64.2M, down 31% from $93.6M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Repertoire Partners withdrew a net $19.7M in Q3 2023, closing 7 positions and reducing 5 holdings. Its most notable exit was Tabula Rasa HealthCare, Inc. Common Stock, an estimated $2.89M position sold in full.
By sector, the portfolio is most concentrated in Financials at 62% of assets, up from 59% a quarter earlier, followed by Materials and Communication Services.
Against the trend, Repertoire Partners opened a new position in Sotera Health worth $2.1M.
- Repertoire Partners's largest Q3 2023 buy was Sotera Health: 140,000 shares worth $2.1M.
- Repertoire Partners added most to Clarivate in Q3 2023, an estimated $1.12M increase.
- Repertoire Partners's biggest Q3 2023 reduction was Octave Specialty Group, cutting an estimated $9.69M.
- Repertoire Partners fully exited Tabula Rasa HealthCare, Inc. Common Stock in Q3 2023, selling an estimated $2.89M.
- Repertoire Partners's ten largest holdings make up 94% of its $64.2M portfolio in Q3 2023.
- Repertoire Partners opened 9 new positions and closed 7 in Q3 2023.
- Repertoire Partners's portfolio value fell 31% quarter-over-quarter to $64.2M.
Based on Repertoire Partners's 13F filing for Q3 2023, filed 14 Nov 2023.